GlassScriptPhysician profile
Kristen Erickstad
NPI 1972894616
$11,386.59
in general payments reported to CMS, 2019-2025
49 companies · $1,847 in 2025
The $1,847 reported for 2025 was more than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,212 · 2020: $1,402 · 2021: $1,912 · 2022: $1,655 · 2023: $2,078 · 2024: $1,281 · 2025: $1,847.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,206.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $2,408.83 | 2019-2025 | Enbrel, Evenity, Otezla |
| Abbvie INC. | $1,958.57 | 2019-2025 | |
| Ucb, INC. | $913.17 | 2019-2025 | Bimzelx, Cimzia |
| Lilly USA, LLC | $811.54 | 2019-2025 | Taltz, Mounjaro, Trulicity |
| Glaxosmithkline, LLC. | $608.03 | 2019-2025 | Benlysta, Shingrix, Arexvy |
| Pfizer INC. | $585.27 | 2019-2025 | |
| Janssen Biotech, INC. | $520.65 | 2019-2025 | Tremfya, Simponi, Simponi Aria |
| Astrazeneca Pharmaceuticals LP | $405.28 | 2021-2025 | Saphnelo, Breztri |
| Radius Health, INC. | $385.70 | 2019-2025 | Tymlos |
| Novartis Pharmaceuticals Corporation | $376.69 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $288.16 | 2020-2023 | Orencia |
| Bayer Healthcare Pharmaceuticals INC. | $280.90 | 2021-2025 | |
| Horizon Therapeutics Plc | $197.93 | 2020-2023 | Krystexxa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $187.70 | 2020-2025 | Ofev |
| Daiichi Sankyo INC. | $163.48 | 2021-2022 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristen Erickstad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.